Lifestyle Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Obesity, Women's Health, Insomnia, Sexual Dysfunction, Dermatology, and Smoking); Form (Tablets, Gels, Oral Syrups, Parenteral, Creams, and Chewing Gums); End User (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Clinics, e-Commerce/Online Pharmacies, and Others), and Geography
Report Code: TIPRE00022706 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lifestyle Drugs Market - By Type
1.3.2 Lifestyle Drugs Market - By Form
1.3.3 Lifestyle Drugs Market - By End User
1.3.4 Lifestyle Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIFESTYLE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIFESTYLE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIFESTYLE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. LIFESTYLE DRUGS - GLOBAL MARKET OVERVIEW
6.2. LIFESTYLE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. LIFESTYLE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. OBESITY
7.3.1. Overview
7.3.2. Obesity Market Forecast and Analysis
7.4. WOMEN'S HEALTH
7.4.1. Overview
7.4.2. Women's Health Market Forecast and Analysis
7.5. INSOMNIA
7.5.1. Overview
7.5.2. Insomnia Market Forecast and Analysis
7.6. SEXUAL DYSFUNCTION
7.6.1. Overview
7.6.2. Sexual Dysfunction Market Forecast and Analysis
7.7. DERMATOLOGY
7.7.1. Overview
7.7.2. Dermatology Market Forecast and Analysis
7.8. SMOKING
7.8.1. Overview
7.8.2. Smoking Market Forecast and Analysis
8. LIFESTYLE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - FORM
8.1. OVERVIEW
8.2. FORM MARKET FORECASTS AND ANALYSIS
8.3. TABLETS
8.3.1. Overview
8.3.2. Tablets Market Forecast and Analysis
8.4. GELS
8.4.1. Overview
8.4.2. Gels Market Forecast and Analysis
8.5. ORAL SYRUPS
8.5.1. Overview
8.5.2. Oral Syrups Market Forecast and Analysis
8.6. PARENTERAL
8.6.1. Overview
8.6.2. Parenteral Market Forecast and Analysis
8.7. CREAMS
8.7.1. Overview
8.7.2. Creams Market Forecast and Analysis
8.8. CHEWING GUMS
8.8.1. Overview
8.8.2. Chewing Gums Market Forecast and Analysis
9. LIFESTYLE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. CLINICS
9.6.1. Overview
9.6.2. Clinics Market Forecast and Analysis
9.7. E-COMMERCE/ONLINE PHARMACIES
9.7.1. Overview
9.7.2. e-Commerce/Online Pharmacies Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. LIFESTYLE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Lifestyle Drugs Market Overview
10.1.2 North America Lifestyle Drugs Market Forecasts and Analysis
10.1.3 North America Lifestyle Drugs Market Forecasts and Analysis - By Type
10.1.4 North America Lifestyle Drugs Market Forecasts and Analysis - By Form
10.1.5 North America Lifestyle Drugs Market Forecasts and Analysis - By End User
10.1.6 North America Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Lifestyle Drugs Market
10.1.6.1.1 United States Lifestyle Drugs Market by Type
10.1.6.1.2 United States Lifestyle Drugs Market by Form
10.1.6.1.3 United States Lifestyle Drugs Market by End User
10.1.6.2 Canada Lifestyle Drugs Market
10.1.6.2.1 Canada Lifestyle Drugs Market by Type
10.1.6.2.2 Canada Lifestyle Drugs Market by Form
10.1.6.2.3 Canada Lifestyle Drugs Market by End User
10.1.6.3 Mexico Lifestyle Drugs Market
10.1.6.3.1 Mexico Lifestyle Drugs Market by Type
10.1.6.3.2 Mexico Lifestyle Drugs Market by Form
10.1.6.3.3 Mexico Lifestyle Drugs Market by End User
10.2. EUROPE
10.2.1 Europe Lifestyle Drugs Market Overview
10.2.2 Europe Lifestyle Drugs Market Forecasts and Analysis
10.2.3 Europe Lifestyle Drugs Market Forecasts and Analysis - By Type
10.2.4 Europe Lifestyle Drugs Market Forecasts and Analysis - By Form
10.2.5 Europe Lifestyle Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Lifestyle Drugs Market
10.2.6.1.1 Germany Lifestyle Drugs Market by Type
10.2.6.1.2 Germany Lifestyle Drugs Market by Form
10.2.6.1.3 Germany Lifestyle Drugs Market by End User
10.2.6.2 France Lifestyle Drugs Market
10.2.6.2.1 France Lifestyle Drugs Market by Type
10.2.6.2.2 France Lifestyle Drugs Market by Form
10.2.6.2.3 France Lifestyle Drugs Market by End User
10.2.6.3 Italy Lifestyle Drugs Market
10.2.6.3.1 Italy Lifestyle Drugs Market by Type
10.2.6.3.2 Italy Lifestyle Drugs Market by Form
10.2.6.3.3 Italy Lifestyle Drugs Market by End User
10.2.6.4 Spain Lifestyle Drugs Market
10.2.6.4.1 Spain Lifestyle Drugs Market by Type
10.2.6.4.2 Spain Lifestyle Drugs Market by Form
10.2.6.4.3 Spain Lifestyle Drugs Market by End User
10.2.6.5 United Kingdom Lifestyle Drugs Market
10.2.6.5.1 United Kingdom Lifestyle Drugs Market by Type
10.2.6.5.2 United Kingdom Lifestyle Drugs Market by Form
10.2.6.5.3 United Kingdom Lifestyle Drugs Market by End User
10.2.6.6 Rest of Europe Lifestyle Drugs Market
10.2.6.6.1 Rest of Europe Lifestyle Drugs Market by Type
10.2.6.6.2 Rest of Europe Lifestyle Drugs Market by Form
10.2.6.6.3 Rest of Europe Lifestyle Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Lifestyle Drugs Market Overview
10.3.2 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis - By Form
10.3.5 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Lifestyle Drugs Market
10.3.6.1.1 Australia Lifestyle Drugs Market by Type
10.3.6.1.2 Australia Lifestyle Drugs Market by Form
10.3.6.1.3 Australia Lifestyle Drugs Market by End User
10.3.6.2 China Lifestyle Drugs Market
10.3.6.2.1 China Lifestyle Drugs Market by Type
10.3.6.2.2 China Lifestyle Drugs Market by Form
10.3.6.2.3 China Lifestyle Drugs Market by End User
10.3.6.3 India Lifestyle Drugs Market
10.3.6.3.1 India Lifestyle Drugs Market by Type
10.3.6.3.2 India Lifestyle Drugs Market by Form
10.3.6.3.3 India Lifestyle Drugs Market by End User
10.3.6.4 Japan Lifestyle Drugs Market
10.3.6.4.1 Japan Lifestyle Drugs Market by Type
10.3.6.4.2 Japan Lifestyle Drugs Market by Form
10.3.6.4.3 Japan Lifestyle Drugs Market by End User
10.3.6.5 South Korea Lifestyle Drugs Market
10.3.6.5.1 South Korea Lifestyle Drugs Market by Type
10.3.6.5.2 South Korea Lifestyle Drugs Market by Form
10.3.6.5.3 South Korea Lifestyle Drugs Market by End User
10.3.6.6 Rest of Asia-Pacific Lifestyle Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Lifestyle Drugs Market by Type
10.3.6.6.2 Rest of Asia-Pacific Lifestyle Drugs Market by Form
10.3.6.6.3 Rest of Asia-Pacific Lifestyle Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Lifestyle Drugs Market Overview
10.4.2 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis - By Form
10.4.5 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Lifestyle Drugs Market
10.4.6.1.1 South Africa Lifestyle Drugs Market by Type
10.4.6.1.2 South Africa Lifestyle Drugs Market by Form
10.4.6.1.3 South Africa Lifestyle Drugs Market by End User
10.4.6.2 Saudi Arabia Lifestyle Drugs Market
10.4.6.2.1 Saudi Arabia Lifestyle Drugs Market by Type
10.4.6.2.2 Saudi Arabia Lifestyle Drugs Market by Form
10.4.6.2.3 Saudi Arabia Lifestyle Drugs Market by End User
10.4.6.3 U.A.E Lifestyle Drugs Market
10.4.6.3.1 U.A.E Lifestyle Drugs Market by Type
10.4.6.3.2 U.A.E Lifestyle Drugs Market by Form
10.4.6.3.3 U.A.E Lifestyle Drugs Market by End User
10.4.6.4 Rest of Middle East and Africa Lifestyle Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Lifestyle Drugs Market by Type
10.4.6.4.2 Rest of Middle East and Africa Lifestyle Drugs Market by Form
10.4.6.4.3 Rest of Middle East and Africa Lifestyle Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Lifestyle Drugs Market Overview
10.5.2 South and Central America Lifestyle Drugs Market Forecasts and Analysis
10.5.3 South and Central America Lifestyle Drugs Market Forecasts and Analysis - By Type
10.5.4 South and Central America Lifestyle Drugs Market Forecasts and Analysis - By Form
10.5.5 South and Central America Lifestyle Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Lifestyle Drugs Market
10.5.6.1.1 Brazil Lifestyle Drugs Market by Type
10.5.6.1.2 Brazil Lifestyle Drugs Market by Form
10.5.6.1.3 Brazil Lifestyle Drugs Market by End User
10.5.6.2 Argentina Lifestyle Drugs Market
10.5.6.2.1 Argentina Lifestyle Drugs Market by Type
10.5.6.2.2 Argentina Lifestyle Drugs Market by Form
10.5.6.2.3 Argentina Lifestyle Drugs Market by End User
10.5.6.3 Rest of South and Central America Lifestyle Drugs Market
10.5.6.3.1 Rest of South and Central America Lifestyle Drugs Market by Type
10.5.6.3.2 Rest of South and Central America Lifestyle Drugs Market by Form
10.5.6.3.3 Rest of South and Central America Lifestyle Drugs Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LIFESTYLE DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. LIFESTYLE DRUGS MARKET, KEY COMPANY PROFILES
13.1. ALLERGAN
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BMS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ELI LILLY
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GALDERMA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERCK
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PFIZER
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NOVARTIS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ASTRAZENECA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SANOFI
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. VALEANT PHARMACEUTICALS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lifestyle Drugs Market - By Type
1.3.2 Lifestyle Drugs Market - By Form
1.3.3 Lifestyle Drugs Market - By End User
1.3.4 Lifestyle Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIFESTYLE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIFESTYLE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIFESTYLE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. LIFESTYLE DRUGS - GLOBAL MARKET OVERVIEW
6.2. LIFESTYLE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. LIFESTYLE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. OBESITY
7.3.1. Overview
7.3.2. Obesity Market Forecast and Analysis
7.4. WOMEN'S HEALTH
7.4.1. Overview
7.4.2. Women's Health Market Forecast and Analysis
7.5. INSOMNIA
7.5.1. Overview
7.5.2. Insomnia Market Forecast and Analysis
7.6. SEXUAL DYSFUNCTION
7.6.1. Overview
7.6.2. Sexual Dysfunction Market Forecast and Analysis
7.7. DERMATOLOGY
7.7.1. Overview
7.7.2. Dermatology Market Forecast and Analysis
7.8. SMOKING
7.8.1. Overview
7.8.2. Smoking Market Forecast and Analysis
8. LIFESTYLE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - FORM
8.1. OVERVIEW
8.2. FORM MARKET FORECASTS AND ANALYSIS
8.3. TABLETS
8.3.1. Overview
8.3.2. Tablets Market Forecast and Analysis
8.4. GELS
8.4.1. Overview
8.4.2. Gels Market Forecast and Analysis
8.5. ORAL SYRUPS
8.5.1. Overview
8.5.2. Oral Syrups Market Forecast and Analysis
8.6. PARENTERAL
8.6.1. Overview
8.6.2. Parenteral Market Forecast and Analysis
8.7. CREAMS
8.7.1. Overview
8.7.2. Creams Market Forecast and Analysis
8.8. CHEWING GUMS
8.8.1. Overview
8.8.2. Chewing Gums Market Forecast and Analysis
9. LIFESTYLE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. CLINICS
9.6.1. Overview
9.6.2. Clinics Market Forecast and Analysis
9.7. E-COMMERCE/ONLINE PHARMACIES
9.7.1. Overview
9.7.2. e-Commerce/Online Pharmacies Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. LIFESTYLE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Lifestyle Drugs Market Overview
10.1.2 North America Lifestyle Drugs Market Forecasts and Analysis
10.1.3 North America Lifestyle Drugs Market Forecasts and Analysis - By Type
10.1.4 North America Lifestyle Drugs Market Forecasts and Analysis - By Form
10.1.5 North America Lifestyle Drugs Market Forecasts and Analysis - By End User
10.1.6 North America Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Lifestyle Drugs Market
10.1.6.1.1 United States Lifestyle Drugs Market by Type
10.1.6.1.2 United States Lifestyle Drugs Market by Form
10.1.6.1.3 United States Lifestyle Drugs Market by End User
10.1.6.2 Canada Lifestyle Drugs Market
10.1.6.2.1 Canada Lifestyle Drugs Market by Type
10.1.6.2.2 Canada Lifestyle Drugs Market by Form
10.1.6.2.3 Canada Lifestyle Drugs Market by End User
10.1.6.3 Mexico Lifestyle Drugs Market
10.1.6.3.1 Mexico Lifestyle Drugs Market by Type
10.1.6.3.2 Mexico Lifestyle Drugs Market by Form
10.1.6.3.3 Mexico Lifestyle Drugs Market by End User
10.2. EUROPE
10.2.1 Europe Lifestyle Drugs Market Overview
10.2.2 Europe Lifestyle Drugs Market Forecasts and Analysis
10.2.3 Europe Lifestyle Drugs Market Forecasts and Analysis - By Type
10.2.4 Europe Lifestyle Drugs Market Forecasts and Analysis - By Form
10.2.5 Europe Lifestyle Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Lifestyle Drugs Market
10.2.6.1.1 Germany Lifestyle Drugs Market by Type
10.2.6.1.2 Germany Lifestyle Drugs Market by Form
10.2.6.1.3 Germany Lifestyle Drugs Market by End User
10.2.6.2 France Lifestyle Drugs Market
10.2.6.2.1 France Lifestyle Drugs Market by Type
10.2.6.2.2 France Lifestyle Drugs Market by Form
10.2.6.2.3 France Lifestyle Drugs Market by End User
10.2.6.3 Italy Lifestyle Drugs Market
10.2.6.3.1 Italy Lifestyle Drugs Market by Type
10.2.6.3.2 Italy Lifestyle Drugs Market by Form
10.2.6.3.3 Italy Lifestyle Drugs Market by End User
10.2.6.4 Spain Lifestyle Drugs Market
10.2.6.4.1 Spain Lifestyle Drugs Market by Type
10.2.6.4.2 Spain Lifestyle Drugs Market by Form
10.2.6.4.3 Spain Lifestyle Drugs Market by End User
10.2.6.5 United Kingdom Lifestyle Drugs Market
10.2.6.5.1 United Kingdom Lifestyle Drugs Market by Type
10.2.6.5.2 United Kingdom Lifestyle Drugs Market by Form
10.2.6.5.3 United Kingdom Lifestyle Drugs Market by End User
10.2.6.6 Rest of Europe Lifestyle Drugs Market
10.2.6.6.1 Rest of Europe Lifestyle Drugs Market by Type
10.2.6.6.2 Rest of Europe Lifestyle Drugs Market by Form
10.2.6.6.3 Rest of Europe Lifestyle Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Lifestyle Drugs Market Overview
10.3.2 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis - By Form
10.3.5 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Lifestyle Drugs Market
10.3.6.1.1 Australia Lifestyle Drugs Market by Type
10.3.6.1.2 Australia Lifestyle Drugs Market by Form
10.3.6.1.3 Australia Lifestyle Drugs Market by End User
10.3.6.2 China Lifestyle Drugs Market
10.3.6.2.1 China Lifestyle Drugs Market by Type
10.3.6.2.2 China Lifestyle Drugs Market by Form
10.3.6.2.3 China Lifestyle Drugs Market by End User
10.3.6.3 India Lifestyle Drugs Market
10.3.6.3.1 India Lifestyle Drugs Market by Type
10.3.6.3.2 India Lifestyle Drugs Market by Form
10.3.6.3.3 India Lifestyle Drugs Market by End User
10.3.6.4 Japan Lifestyle Drugs Market
10.3.6.4.1 Japan Lifestyle Drugs Market by Type
10.3.6.4.2 Japan Lifestyle Drugs Market by Form
10.3.6.4.3 Japan Lifestyle Drugs Market by End User
10.3.6.5 South Korea Lifestyle Drugs Market
10.3.6.5.1 South Korea Lifestyle Drugs Market by Type
10.3.6.5.2 South Korea Lifestyle Drugs Market by Form
10.3.6.5.3 South Korea Lifestyle Drugs Market by End User
10.3.6.6 Rest of Asia-Pacific Lifestyle Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Lifestyle Drugs Market by Type
10.3.6.6.2 Rest of Asia-Pacific Lifestyle Drugs Market by Form
10.3.6.6.3 Rest of Asia-Pacific Lifestyle Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Lifestyle Drugs Market Overview
10.4.2 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis - By Form
10.4.5 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Lifestyle Drugs Market
10.4.6.1.1 South Africa Lifestyle Drugs Market by Type
10.4.6.1.2 South Africa Lifestyle Drugs Market by Form
10.4.6.1.3 South Africa Lifestyle Drugs Market by End User
10.4.6.2 Saudi Arabia Lifestyle Drugs Market
10.4.6.2.1 Saudi Arabia Lifestyle Drugs Market by Type
10.4.6.2.2 Saudi Arabia Lifestyle Drugs Market by Form
10.4.6.2.3 Saudi Arabia Lifestyle Drugs Market by End User
10.4.6.3 U.A.E Lifestyle Drugs Market
10.4.6.3.1 U.A.E Lifestyle Drugs Market by Type
10.4.6.3.2 U.A.E Lifestyle Drugs Market by Form
10.4.6.3.3 U.A.E Lifestyle Drugs Market by End User
10.4.6.4 Rest of Middle East and Africa Lifestyle Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Lifestyle Drugs Market by Type
10.4.6.4.2 Rest of Middle East and Africa Lifestyle Drugs Market by Form
10.4.6.4.3 Rest of Middle East and Africa Lifestyle Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Lifestyle Drugs Market Overview
10.5.2 South and Central America Lifestyle Drugs Market Forecasts and Analysis
10.5.3 South and Central America Lifestyle Drugs Market Forecasts and Analysis - By Type
10.5.4 South and Central America Lifestyle Drugs Market Forecasts and Analysis - By Form
10.5.5 South and Central America Lifestyle Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America Lifestyle Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Lifestyle Drugs Market
10.5.6.1.1 Brazil Lifestyle Drugs Market by Type
10.5.6.1.2 Brazil Lifestyle Drugs Market by Form
10.5.6.1.3 Brazil Lifestyle Drugs Market by End User
10.5.6.2 Argentina Lifestyle Drugs Market
10.5.6.2.1 Argentina Lifestyle Drugs Market by Type
10.5.6.2.2 Argentina Lifestyle Drugs Market by Form
10.5.6.2.3 Argentina Lifestyle Drugs Market by End User
10.5.6.3 Rest of South and Central America Lifestyle Drugs Market
10.5.6.3.1 Rest of South and Central America Lifestyle Drugs Market by Type
10.5.6.3.2 Rest of South and Central America Lifestyle Drugs Market by Form
10.5.6.3.3 Rest of South and Central America Lifestyle Drugs Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LIFESTYLE DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. LIFESTYLE DRUGS MARKET, KEY COMPANY PROFILES
13.1. ALLERGAN
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BMS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ELI LILLY
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GALDERMA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERCK
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PFIZER
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NOVARTIS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ASTRAZENECA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SANOFI
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. VALEANT PHARMACEUTICALS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Allergan
2. BMS
3. Eli Lilly
4. Galderma
5. Merck
6. Pfizer
7. Novartis
8. AstraZeneca
9. Sanofi
10. Valeant Pharmaceuticals
11. Johnson & Johnson
1. Allergan
2. BMS
3. Eli Lilly
4. Galderma
5. Merck
6. Pfizer
7. Novartis
8. AstraZeneca
9. Sanofi
10. Valeant Pharmaceuticals
11. Johnson & Johnson
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount